Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
14.60
+0.16 (1.11%)
Oct 3, 2025, 4:00 PM EDT - Market closed
Takeda Pharmaceutical Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Takeda Pharmaceutical.
Price Target: $ (0.00%)
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Takeda Pharmaceutical.
Recommendation Trends
Rating | Dec '22 | Jan '23 | Feb '23 | Mar '23 | Apr '23 | May '23 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 1 | 1 | 0 |
Buy | 1 | 1 | 1 | 1 | 1 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 2 | 2 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
TD Cowen | TD Cowen | Buy Maintains $30 → $20 | Buy | Maintains | $30 → $20 | +36.99% | May 16, 2023 |
TD Cowen | TD Cowen | Buy Maintains $24 → $30 | Buy | Maintains | $24 → $30 | +105.48% | Apr 4, 2023 |
B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $20 | Hold → Strong Buy | Upgrades | $20 | +36.99% | Mar 16, 2023 |
Cowen & Co. | Cowen & Co. | Hold → Buy Upgrades $21 → $24 | Hold → Buy | Upgrades | $21 → $24 | +64.38% | Jul 19, 2022 |
Cowen & Co. | Cowen & Co. | Hold Initiates $20 | Hold | Initiates | $20 | +33.56% | Nov 1, 2019 |
Financial Forecast
Revenue This Year
4,589.89B
from 4,581.55B
Increased by 0.18%
Revenue Next Year
4,615.43B
from 4,589.89B
Increased by 0.56%
EPS This Year
155.64
from 67.23
Increased by 131.51%
EPS Next Year
197.35
from 155.64
Increased by 26.80%
Financial currency is JPY. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2026 | 2027 | 2028 |
---|---|---|---|
High | 4.9T | 5.0T | |
Avg | 4.6T | 4.6T | |
Low | 4.3T | 4.2T |
Revenue Growth
Revenue Growth | 2026 | 2027 | 2028 |
---|---|---|---|
High | 7.2% | 8.3% | |
Avg | 0.2% | 0.6% | |
Low | -6.9% | -7.6% |
EPS Forecast
EPS | 2026 | 2027 | 2028 |
---|---|---|---|
High | 205.28 | 268.50 | |
Avg | 155.64 | 197.35 | |
Low | 132.59 | 98.98 |
EPS Growth
EPS Growth | 2026 | 2027 | 2028 |
---|---|---|---|
High | 205.3% | 72.5% | |
Avg | 131.5% | 26.8% | |
Low | 97.2% | -36.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.